title: Reasons for pretreatment attrition and dropout from methylphenidate in adults with attention-deficit/hyperactivity disorder: the role of comorbidities.
authors.forename: Marcelo M
authors.initials: MM
authors.lastname: Victor
authors.forename: Eugenio H
authors.initials: EH
authors.lastname: Grevet
authors.forename: Carlos A I
authors.initials: CA
authors.lastname: Salgado
authors.forename: Katiane L
authors.initials: KL
authors.lastname: Silva
authors.forename: Nyvia O
authors.initials: NO
authors.lastname: Sousa
authors.forename: Rafael G
authors.initials: RG
authors.lastname: Karam
authors.forename: Eduardo S
authors.initials: ES
authors.lastname: Vitola
authors.forename: Felipe A
authors.initials: FA
authors.lastname: Picon
authors.forename: Gregory D
authors.initials: GD
authors.lastname: Zeni
authors.forename: Veronica
authors.initials: V
authors.lastname: Contini
authors.forename: Luis A P
authors.initials: LA
authors.lastname: Rohde
authors.forename: Paulo
authors.initials: P
authors.lastname: Belmonte-de-Abreu
authors.forename: Claiton H D
authors.initials: CH
authors.lastname: Bau
mesh_terms: D000367:Age Factors; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000453:epidemiology* / Q000523:psychology; D015897:Comorbidity; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D010349:Patient Compliance / Q000523:psychology; D010352:Patient Dropouts / Q000523:psychology
chemical_list: D008774:Methylphenidate